Atlas Trials

A Study Investigating the Safety, Tolerability, and Efficacy of Elamipretide Topical Ophthalmic Solution for the Treatment of Fuchs' Corneal Endothelial Dystrophy (FCED)

Clinical trial NCT02653391 · COMPLETED

Trial details

NCT number
NCT02653391
Sponsor
Stealth BioTherapeutics Inc.
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Fuchs' Corneal Endothelial Dystrophy (FCED)
Start date
2016-02-01
Primary completion
2018-03-01
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.